nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.122	0.173	CbGbCtD
Cabazitaxel—ABCG2—Leflunomide—systemic scleroderma	0.0912	0.13	CbGbCtD
Cabazitaxel—CYP2C8—Mometasone—systemic scleroderma	0.0754	0.107	CbGbCtD
Cabazitaxel—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0709	0.101	CbGbCtD
Cabazitaxel—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0563	0.0801	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—systemic scleroderma	0.0488	0.0694	CbGbCtD
Cabazitaxel—ABCB1—Lisinopril—systemic scleroderma	0.0345	0.049	CbGbCtD
Cabazitaxel—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0312	0.0444	CbGbCtD
Cabazitaxel—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.03	0.0427	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—systemic scleroderma	0.0284	0.0404	CbGbCtD
Cabazitaxel—ABCB1—Captopril—systemic scleroderma	0.0258	0.0367	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—systemic scleroderma	0.0226	0.0321	CbGbCtD
Cabazitaxel—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0203	0.0289	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—systemic scleroderma	0.0162	0.0231	CbGbCtD
Cabazitaxel—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0122	0.0173	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—systemic scleroderma	0.00973	0.0138	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—systemic scleroderma	0.00814	0.0116	CbGbCtD
Cabazitaxel—TUBB3—connective tissue—systemic scleroderma	0.0028	0.0489	CbGeAlD
Cabazitaxel—TUBA4A—connective tissue—systemic scleroderma	0.00213	0.0372	CbGeAlD
Cabazitaxel—TUBB3—digestive system—systemic scleroderma	0.00202	0.0353	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—systemic scleroderma	0.00195	0.034	CbGeAlD
Cabazitaxel—TUBA4A—skin of body—systemic scleroderma	0.00192	0.0336	CbGeAlD
Cabazitaxel—TUBB4A—connective tissue—systemic scleroderma	0.0017	0.0298	CbGeAlD
Cabazitaxel—TUBB3—lung—systemic scleroderma	0.00169	0.0295	CbGeAlD
Cabazitaxel—TUBB2B—connective tissue—systemic scleroderma	0.00165	0.0288	CbGeAlD
Cabazitaxel—TUBB2A—connective tissue—systemic scleroderma	0.00155	0.0271	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—systemic scleroderma	0.00154	0.0269	CbGeAlD
Cabazitaxel—TUBA4A—digestive system—systemic scleroderma	0.00154	0.0268	CbGeAlD
Cabazitaxel—SLCO1B3—lung—systemic scleroderma	0.00148	0.0258	CbGeAlD
Cabazitaxel—TUBA4A—tendon—systemic scleroderma	0.00146	0.0255	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—systemic scleroderma	0.00143	0.0249	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00142	0.0248	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—systemic scleroderma	0.0014	0.0245	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—systemic scleroderma	0.0014	0.0244	CbGeAlD
Cabazitaxel—TUBB6—skin of body—systemic scleroderma	0.00138	0.0241	CbGeAlD
Cabazitaxel—TUBB4B—connective tissue—systemic scleroderma	0.00133	0.0232	CbGeAlD
Cabazitaxel—TUBA4A—lung—systemic scleroderma	0.00128	0.0224	CbGeAlD
Cabazitaxel—TUBB4A—digestive system—systemic scleroderma	0.00123	0.0215	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—systemic scleroderma	0.00122	0.0212	CbGeAlD
Cabazitaxel—TUBB4B—skin of body—systemic scleroderma	0.0012	0.021	CbGeAlD
Cabazitaxel—TUBB2B—digestive system—systemic scleroderma	0.00119	0.0208	CbGeAlD
Cabazitaxel—TUBB4A—tendon—systemic scleroderma	0.00117	0.0205	CbGeAlD
Cabazitaxel—TUBB2B—tendon—systemic scleroderma	0.00113	0.0198	CbGeAlD
Cabazitaxel—TUBB2A—digestive system—systemic scleroderma	0.00112	0.0196	CbGeAlD
Cabazitaxel—TUBB6—digestive system—systemic scleroderma	0.0011	0.0193	CbGeAlD
Cabazitaxel—TUBB—tendon—systemic scleroderma	0.00107	0.0187	CbGeAlD
Cabazitaxel—TUBB2A—tendon—systemic scleroderma	0.00107	0.0186	CbGeAlD
Cabazitaxel—TUBB6—tendon—systemic scleroderma	0.00105	0.0184	CbGeAlD
Cabazitaxel—TUBB4A—lung—systemic scleroderma	0.00103	0.018	CbGeAlD
Cabazitaxel—SLCO1B1—digestive system—systemic scleroderma	0.00102	0.0179	CbGeAlD
Cabazitaxel—TUBB2B—lung—systemic scleroderma	0.000994	0.0174	CbGeAlD
Cabazitaxel—TUBB4B—digestive system—systemic scleroderma	0.00096	0.0168	CbGeAlD
Cabazitaxel—TUBB—lung—systemic scleroderma	0.00094	0.0164	CbGeAlD
Cabazitaxel—TUBB2A—lung—systemic scleroderma	0.000935	0.0163	CbGeAlD
Cabazitaxel—TUBB6—lung—systemic scleroderma	0.000923	0.0161	CbGeAlD
Cabazitaxel—TUBB4B—tendon—systemic scleroderma	0.000914	0.016	CbGeAlD
Cabazitaxel—TUBB4B—lung—systemic scleroderma	0.000802	0.014	CbGeAlD
Cabazitaxel—ABCB1—blood vessel—systemic scleroderma	0.000754	0.0132	CbGeAlD
Cabazitaxel—CYP3A5—digestive system—systemic scleroderma	0.000526	0.00919	CbGeAlD
Cabazitaxel—ABCG2—lung—systemic scleroderma	0.000473	0.00826	CbGeAlD
Cabazitaxel—CYP3A5—lung—systemic scleroderma	0.000439	0.00767	CbGeAlD
Cabazitaxel—CYP3A4—digestive system—systemic scleroderma	0.000395	0.00689	CbGeAlD
Cabazitaxel—ABCB1—digestive system—systemic scleroderma	0.000279	0.00488	CbGeAlD
Cabazitaxel—Anorexia—Mycophenolic acid—systemic scleroderma	0.000269	0.00112	CcSEcCtD
Cabazitaxel—Abdominal distension—Prednisone—systemic scleroderma	0.000267	0.00112	CcSEcCtD
Cabazitaxel—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00112	CcSEcCtD
Cabazitaxel—Paraesthesia—Leflunomide—systemic scleroderma	0.000266	0.00111	CcSEcCtD
Cabazitaxel—Arthralgia—Lisinopril—systemic scleroderma	0.000265	0.00111	CcSEcCtD
Cabazitaxel—Chest pain—Lisinopril—systemic scleroderma	0.000265	0.00111	CcSEcCtD
Cabazitaxel—Myalgia—Lisinopril—systemic scleroderma	0.000265	0.00111	CcSEcCtD
Cabazitaxel—Anxiety—Lisinopril—systemic scleroderma	0.000264	0.0011	CcSEcCtD
Cabazitaxel—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000264	0.0011	CcSEcCtD
Cabazitaxel—Dyspnoea—Leflunomide—systemic scleroderma	0.000264	0.0011	CcSEcCtD
Cabazitaxel—Hypotension—Mycophenolic acid—systemic scleroderma	0.000264	0.0011	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000263	0.0011	CcSEcCtD
Cabazitaxel—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000262	0.0011	CcSEcCtD
Cabazitaxel—Discomfort—Lisinopril—systemic scleroderma	0.000262	0.00109	CcSEcCtD
Cabazitaxel—Lethargy—Methotrexate—systemic scleroderma	0.000262	0.00109	CcSEcCtD
Cabazitaxel—Dyspepsia—Leflunomide—systemic scleroderma	0.000261	0.00109	CcSEcCtD
Cabazitaxel—Vomiting—Mometasone—systemic scleroderma	0.00026	0.00109	CcSEcCtD
Cabazitaxel—Dry mouth—Lisinopril—systemic scleroderma	0.000259	0.00108	CcSEcCtD
Cabazitaxel—Feeling abnormal—Azathioprine—systemic scleroderma	0.000258	0.00108	CcSEcCtD
Cabazitaxel—Asthenia—Captopril—systemic scleroderma	0.000258	0.00108	CcSEcCtD
Cabazitaxel—Decreased appetite—Leflunomide—systemic scleroderma	0.000257	0.00107	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000257	0.00107	CcSEcCtD
Cabazitaxel—Confusional state—Lisinopril—systemic scleroderma	0.000256	0.00107	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000256	0.00107	CcSEcCtD
Cabazitaxel—Headache—Mometasone—systemic scleroderma	0.000256	0.00107	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000255	0.00107	CcSEcCtD
Cabazitaxel—Fatigue—Leflunomide—systemic scleroderma	0.000255	0.00107	CcSEcCtD
Cabazitaxel—Oedema—Lisinopril—systemic scleroderma	0.000254	0.00106	CcSEcCtD
Cabazitaxel—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000254	0.00106	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00106	CcSEcCtD
Cabazitaxel—Pain—Leflunomide—systemic scleroderma	0.000253	0.00106	CcSEcCtD
Cabazitaxel—Constipation—Leflunomide—systemic scleroderma	0.000253	0.00106	CcSEcCtD
Cabazitaxel—Infection—Lisinopril—systemic scleroderma	0.000253	0.00106	CcSEcCtD
Cabazitaxel—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00105	CcSEcCtD
Cabazitaxel—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000252	0.00105	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000249	0.00104	CcSEcCtD
Cabazitaxel—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000249	0.00104	CcSEcCtD
Cabazitaxel—Neutropenia—Prednisone—systemic scleroderma	0.000248	0.00104	CcSEcCtD
Cabazitaxel—Tachycardia—Lisinopril—systemic scleroderma	0.000248	0.00104	CcSEcCtD
Cabazitaxel—Abdominal pain—Azathioprine—systemic scleroderma	0.000248	0.00103	CcSEcCtD
Cabazitaxel—Body temperature increased—Azathioprine—systemic scleroderma	0.000248	0.00103	CcSEcCtD
Cabazitaxel—Skin disorder—Lisinopril—systemic scleroderma	0.000247	0.00103	CcSEcCtD
Cabazitaxel—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00103	CcSEcCtD
Cabazitaxel—Diarrhoea—Captopril—systemic scleroderma	0.000246	0.00103	CcSEcCtD
Cabazitaxel—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000245	0.00103	CcSEcCtD
Cabazitaxel—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00102	CcSEcCtD
Cabazitaxel—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000244	0.00102	CcSEcCtD
Cabazitaxel—Feeling abnormal—Leflunomide—systemic scleroderma	0.000244	0.00102	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000244	0.00102	CcSEcCtD
Cabazitaxel—Fatigue—Mycophenolic acid—systemic scleroderma	0.000243	0.00102	CcSEcCtD
Cabazitaxel—Nausea—Mometasone—systemic scleroderma	0.000243	0.00101	CcSEcCtD
Cabazitaxel—Anorexia—Lisinopril—systemic scleroderma	0.000242	0.00101	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000242	0.00101	CcSEcCtD
Cabazitaxel—Pain—Mycophenolic acid—systemic scleroderma	0.000241	0.00101	CcSEcCtD
Cabazitaxel—Constipation—Mycophenolic acid—systemic scleroderma	0.000241	0.00101	CcSEcCtD
Cabazitaxel—Weight decreased—Prednisone—systemic scleroderma	0.00024	0.001	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Prednisone—systemic scleroderma	0.00024	0.001	CcSEcCtD
Cabazitaxel—Cough—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000995	CcSEcCtD
Cabazitaxel—Hypotension—Lisinopril—systemic scleroderma	0.000238	0.000993	CcSEcCtD
Cabazitaxel—Dizziness—Captopril—systemic scleroderma	0.000237	0.000992	CcSEcCtD
Cabazitaxel—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000985	CcSEcCtD
Cabazitaxel—Abdominal pain—Leflunomide—systemic scleroderma	0.000234	0.000977	CcSEcCtD
Cabazitaxel—Body temperature increased—Leflunomide—systemic scleroderma	0.000234	0.000977	CcSEcCtD
Cabazitaxel—ABCB1—lung—systemic scleroderma	0.000233	0.00408	CbGeAlD
Cabazitaxel—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000233	0.000972	CcSEcCtD
Cabazitaxel—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000971	CcSEcCtD
Cabazitaxel—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000971	CcSEcCtD
Cabazitaxel—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000971	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000232	0.00097	CcSEcCtD
Cabazitaxel—Breast disorder—Methotrexate—systemic scleroderma	0.000232	0.000969	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000232	0.000968	CcSEcCtD
Cabazitaxel—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000968	CcSEcCtD
Cabazitaxel—Hypersensitivity—Azathioprine—systemic scleroderma	0.000231	0.000964	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000231	0.000964	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000964	CcSEcCtD
Cabazitaxel—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000959	CcSEcCtD
Cabazitaxel—Paraesthesia—Lisinopril—systemic scleroderma	0.000228	0.000954	CcSEcCtD
Cabazitaxel—Vomiting—Captopril—systemic scleroderma	0.000228	0.000954	CcSEcCtD
Cabazitaxel—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00095	CcSEcCtD
Cabazitaxel—Dyspnoea—Lisinopril—systemic scleroderma	0.000227	0.000947	CcSEcCtD
Cabazitaxel—Headache—Captopril—systemic scleroderma	0.000225	0.00094	CcSEcCtD
Cabazitaxel—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000938	CcSEcCtD
Cabazitaxel—Dyspepsia—Lisinopril—systemic scleroderma	0.000224	0.000935	CcSEcCtD
Cabazitaxel—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000223	0.000932	CcSEcCtD
Cabazitaxel—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000223	0.000932	CcSEcCtD
Cabazitaxel—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000931	CcSEcCtD
Cabazitaxel—Infection—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000925	CcSEcCtD
Cabazitaxel—Decreased appetite—Lisinopril—systemic scleroderma	0.000221	0.000923	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00022	0.000917	CcSEcCtD
Cabazitaxel—Fatigue—Lisinopril—systemic scleroderma	0.000219	0.000916	CcSEcCtD
Cabazitaxel—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000913	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000911	CcSEcCtD
Cabazitaxel—Hypersensitivity—Leflunomide—systemic scleroderma	0.000218	0.000911	CcSEcCtD
Cabazitaxel—Pain—Lisinopril—systemic scleroderma	0.000217	0.000908	CcSEcCtD
Cabazitaxel—Constipation—Lisinopril—systemic scleroderma	0.000217	0.000908	CcSEcCtD
Cabazitaxel—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000908	CcSEcCtD
Cabazitaxel—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000904	CcSEcCtD
Cabazitaxel—Diarrhoea—Azathioprine—systemic scleroderma	0.000214	0.000896	CcSEcCtD
Cabazitaxel—Nausea—Captopril—systemic scleroderma	0.000213	0.000891	CcSEcCtD
Cabazitaxel—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000887	CcSEcCtD
Cabazitaxel—Asthenia—Leflunomide—systemic scleroderma	0.000212	0.000887	CcSEcCtD
Cabazitaxel—Feeling abnormal—Lisinopril—systemic scleroderma	0.00021	0.000875	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Prednisone—systemic scleroderma	0.000209	0.000873	CcSEcCtD
Cabazitaxel—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00087	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000208	0.000869	CcSEcCtD
Cabazitaxel—Dysuria—Methotrexate—systemic scleroderma	0.000208	0.000867	CcSEcCtD
Cabazitaxel—Neutropenia—Methotrexate—systemic scleroderma	0.000208	0.000867	CcSEcCtD
Cabazitaxel—Dizziness—Azathioprine—systemic scleroderma	0.000207	0.000866	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000206	0.000862	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000848	CcSEcCtD
Cabazitaxel—Asthenia—Mycophenolic acid—systemic scleroderma	0.000203	0.000846	CcSEcCtD
Cabazitaxel—Diarrhoea—Leflunomide—systemic scleroderma	0.000202	0.000846	CcSEcCtD
Cabazitaxel—Abdominal pain—Lisinopril—systemic scleroderma	0.000201	0.00084	CcSEcCtD
Cabazitaxel—Body temperature increased—Lisinopril—systemic scleroderma	0.000201	0.00084	CcSEcCtD
Cabazitaxel—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000836	CcSEcCtD
Cabazitaxel—Vomiting—Azathioprine—systemic scleroderma	0.000199	0.000832	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—systemic scleroderma	0.000199	0.000831	CcSEcCtD
Cabazitaxel—Eye disorder—Prednisone—systemic scleroderma	0.000199	0.00083	CcSEcCtD
Cabazitaxel—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00083	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—systemic scleroderma	0.000198	0.000827	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—systemic scleroderma	0.000198	0.000827	CcSEcCtD
Cabazitaxel—Flushing—Prednisone—systemic scleroderma	0.000197	0.000824	CcSEcCtD
Cabazitaxel—Headache—Azathioprine—systemic scleroderma	0.000196	0.00082	CcSEcCtD
Cabazitaxel—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000819	CcSEcCtD
Cabazitaxel—Dizziness—Leflunomide—systemic scleroderma	0.000196	0.000817	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—systemic scleroderma	0.000195	0.000813	CcSEcCtD
Cabazitaxel—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000809	CcSEcCtD
Cabazitaxel—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000193	0.000807	CcSEcCtD
Cabazitaxel—Angiopathy—Prednisone—systemic scleroderma	0.000193	0.000806	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—systemic scleroderma	0.000192	0.000804	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000804	CcSEcCtD
Cabazitaxel—Immune system disorder—Prednisone—systemic scleroderma	0.000192	0.000802	CcSEcCtD
Cabazitaxel—Pain—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000796	CcSEcCtD
Cabazitaxel—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000796	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisone—systemic scleroderma	0.00019	0.000793	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—systemic scleroderma	0.000189	0.000788	CcSEcCtD
Cabazitaxel—Vomiting—Leflunomide—systemic scleroderma	0.000188	0.000786	CcSEcCtD
Cabazitaxel—Alopecia—Prednisone—systemic scleroderma	0.000188	0.000785	CcSEcCtD
Cabazitaxel—Hypersensitivity—Lisinopril—systemic scleroderma	0.000187	0.000783	CcSEcCtD
Cabazitaxel—Dizziness—Mycophenolic acid—systemic scleroderma	0.000187	0.00078	CcSEcCtD
Cabazitaxel—Mental disorder—Prednisone—systemic scleroderma	0.000186	0.000778	CcSEcCtD
Cabazitaxel—Nausea—Azathioprine—systemic scleroderma	0.000186	0.000778	CcSEcCtD
Cabazitaxel—Headache—Leflunomide—systemic scleroderma	0.000185	0.000774	CcSEcCtD
Cabazitaxel—Erythema—Prednisone—systemic scleroderma	0.000185	0.000773	CcSEcCtD
Cabazitaxel—Malnutrition—Prednisone—systemic scleroderma	0.000185	0.000773	CcSEcCtD
Cabazitaxel—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000767	CcSEcCtD
Cabazitaxel—Asthenia—Lisinopril—systemic scleroderma	0.000182	0.000762	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000761	CcSEcCtD
Cabazitaxel—Vomiting—Mycophenolic acid—systemic scleroderma	0.00018	0.00075	CcSEcCtD
Cabazitaxel—Headache—Mycophenolic acid—systemic scleroderma	0.000177	0.000739	CcSEcCtD
Cabazitaxel—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000736	CcSEcCtD
Cabazitaxel—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000736	CcSEcCtD
Cabazitaxel—Nausea—Leflunomide—systemic scleroderma	0.000176	0.000734	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000175	0.000733	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—systemic scleroderma	0.000174	0.000727	CcSEcCtD
Cabazitaxel—Diarrhoea—Lisinopril—systemic scleroderma	0.000174	0.000727	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisone—systemic scleroderma	0.000172	0.000717	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—systemic scleroderma	0.000171	0.000714	CcSEcCtD
Cabazitaxel—Dizziness—Lisinopril—systemic scleroderma	0.000168	0.000702	CcSEcCtD
Cabazitaxel—Nausea—Mycophenolic acid—systemic scleroderma	0.000168	0.000701	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—systemic scleroderma	0.000167	0.000697	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—systemic scleroderma	0.000166	0.000695	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—systemic scleroderma	0.000166	0.000694	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—systemic scleroderma	0.000166	0.000692	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—systemic scleroderma	0.000165	0.000689	CcSEcCtD
Cabazitaxel—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000686	CcSEcCtD
Cabazitaxel—Vomiting—Lisinopril—systemic scleroderma	0.000162	0.000675	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—systemic scleroderma	0.000161	0.000673	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—systemic scleroderma	0.00016	0.00067	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00016	0.000669	CcSEcCtD
Cabazitaxel—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000668	CcSEcCtD
Cabazitaxel—Hypertension—Prednisone—systemic scleroderma	0.00016	0.000667	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—systemic scleroderma	0.000159	0.000666	CcSEcCtD
Cabazitaxel—Headache—Lisinopril—systemic scleroderma	0.000159	0.000665	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—systemic scleroderma	0.000158	0.000658	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—systemic scleroderma	0.000158	0.000658	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—systemic scleroderma	0.000157	0.000656	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—systemic scleroderma	0.000157	0.000656	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000156	0.000654	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—systemic scleroderma	0.000156	0.00065	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—systemic scleroderma	0.000156	0.00065	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—systemic scleroderma	0.000155	0.000646	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—systemic scleroderma	0.000155	0.000646	CcSEcCtD
Cabazitaxel—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000637	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—systemic scleroderma	0.000151	0.000633	CcSEcCtD
Cabazitaxel—Nausea—Lisinopril—systemic scleroderma	0.000151	0.000631	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—systemic scleroderma	0.000151	0.000631	CcSEcCtD
Cabazitaxel—Infection—Prednisone—systemic scleroderma	0.00015	0.000627	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—systemic scleroderma	0.00015	0.000625	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—systemic scleroderma	0.000148	0.000619	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—systemic scleroderma	0.000147	0.000616	CcSEcCtD
Cabazitaxel—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000615	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—systemic scleroderma	0.000147	0.000613	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—systemic scleroderma	0.000144	0.000601	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000143	0.000599	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—systemic scleroderma	0.000143	0.000597	CcSEcCtD
Cabazitaxel—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000592	CcSEcCtD
Cabazitaxel—Headache—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000583	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—systemic scleroderma	0.000139	0.000583	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—systemic scleroderma	0.000139	0.00058	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—systemic scleroderma	0.000138	0.000578	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000138	0.000575	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—systemic scleroderma	0.000136	0.000566	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—systemic scleroderma	0.000135	0.000564	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—systemic scleroderma	0.000133	0.000555	CcSEcCtD
Cabazitaxel—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000553	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—systemic scleroderma	0.000132	0.00055	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—systemic scleroderma	0.000132	0.00055	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—systemic scleroderma	0.000132	0.00055	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—systemic scleroderma	0.000131	0.000548	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000131	0.000546	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—systemic scleroderma	0.00013	0.000544	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—systemic scleroderma	0.00013	0.000543	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—systemic scleroderma	0.000129	0.000539	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—systemic scleroderma	0.000127	0.000532	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—systemic scleroderma	0.000125	0.000524	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisone—systemic scleroderma	0.000124	0.00052	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—systemic scleroderma	0.000124	0.000517	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000124	0.000516	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000123	0.000516	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—systemic scleroderma	0.000123	0.000512	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—systemic scleroderma	0.00012	0.000503	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—systemic scleroderma	0.000119	0.000499	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—systemic scleroderma	0.000119	0.000499	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—systemic scleroderma	0.000118	0.000493	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000115	0.00048	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—systemic scleroderma	0.000113	0.000473	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—systemic scleroderma	0.000113	0.00047	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisone—systemic scleroderma	0.000111	0.000465	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—systemic scleroderma	0.000111	0.000464	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—systemic scleroderma	0.00011	0.000458	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000109	0.000455	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—systemic scleroderma	0.000109	0.000455	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—systemic scleroderma	0.000108	0.000453	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—systemic scleroderma	0.000108	0.000451	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—systemic scleroderma	0.000104	0.000434	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—systemic scleroderma	0.000103	0.000432	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000103	0.000431	CcSEcCtD
Cabazitaxel—Dizziness—Prednisone—systemic scleroderma	9.99e-05	0.000417	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—systemic scleroderma	9.98e-05	0.000417	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—systemic scleroderma	9.98e-05	0.000417	CcSEcCtD
Cabazitaxel—Vomiting—Prednisone—systemic scleroderma	9.6e-05	0.000401	CcSEcCtD
Cabazitaxel—Headache—Prednisone—systemic scleroderma	9.46e-05	0.000395	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—systemic scleroderma	9.3e-05	0.000388	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—systemic scleroderma	9.06e-05	0.000378	CcSEcCtD
Cabazitaxel—Nausea—Prednisone—systemic scleroderma	8.97e-05	0.000375	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—systemic scleroderma	8.64e-05	0.000361	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—systemic scleroderma	8.35e-05	0.000349	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—systemic scleroderma	8.02e-05	0.000335	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—systemic scleroderma	7.91e-05	0.00033	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—systemic scleroderma	7.5e-05	0.000313	CcSEcCtD
